# A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension

> **NCT06785454** · PHASE2 · COMPLETED · sponsor: **Mineralys Therapeutics Inc.** · enrollment: 48 (actual)

## Conditions studied

- Obstructive Sleep Apnea
- Hypertension

## Interventions

- **DRUG:** Lorundrostat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06785454
- **Lead sponsor:** Mineralys Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-28
- **Primary completion:** 2025-12-17
- **Final completion:** 2025-12-29
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06785454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06785454, "A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06785454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*